Anti arrhythmic drugs A/Prof Andrew Dean. May 2013
|
|
- Barbara Spencer
- 7 years ago
- Views:
Transcription
1 Anti arrhythmic drugs A/Prof Andrew Dean. May 2013
2 Drugs in arrhythmia Not all arrhythmias need to be treated Anti-arrhythmic drugs have significant side effects and some are pro-arrhythmic None have been shown in drug trials to have long term mortality benefit with the exception of Amiodarone
3 Classifying the drugs Group antiarrhythmic drugs by their clinical effects/indications for use Also group drugs by electrophysiological effects (for example: SA/ AV nodes, refractory periods, QT intervals, anatomical sites of action in the heart) The Vaughan Williams classification is one of the latter. No classification is ideal, as several drugs overlap the categories of actions
4 Drugs for tachyarrhythmias Supraventricular arrhythmias: glycosides (digoxin), beta blockers, adenosine, verapamil Supraventricular and Ventricular arrhythmias: amiodarone, beta blockers, flecainide, sotalol Ventricular arrhythmias: Amiodarone, Lignocaine
5 Drugs for bradyarrhythmias Sinus bradycardias: Atropine, Adrenaline, Isoprenaline Asystole: Adrenaline, Atropine
6 Vaughan Williams Classification - by mechanism of action Class 1: fast sodium channel blockers Class 2: reduce adrenergic effect - beta blockers Class 3: potassium efflux Class 4: calcium channel blockers Other: digoxin, adenosine, magnesium sulphate
7 Beta blockers and CCBs The centrally acting CCBs (Verapamil and Diltiazem) can be regarded as virtually identical to the beta blockers in their effects on conduction Both reduce SA and AV node conduction speed, and may cause AV block, and reduce contractility and 02 demand. They have slightly different roles.
8 Vaughan Williams classification CLASS MECHANISM OF ACTION EXAMPLES 1 Interfere with depolarisation Inhibit fast Na+ channels 1A Quinidine, Disopyramide, Procainamide 1B Lignocaine, Mexilitine, Phenytoin 1C Flecainide 2 Beta Blockers Inhibit beta adrenergic receptors Metoprolol, Atenolol, Propranolol, Sotalol ** 3 Prolong repolarisation Inhibit K+ efflux channels Amiodarone, Bretylium, Sotalol ** 4 CCBs Inhibit slow calcium channels Verapamil, Diltiazem Unclassified Various mechanisms MgS04, Adenosine, Digoxin, Isoprenaline
9 Antiarrhythmics commonly used Red shading = Commonly used VAUGHAN-WILLIAMS CLASS MECHANISM OF ACTION EXAMPLES 1 Fast Na+ Channel Blockers 1A Quinidine, Disopyramide, Procainamide 1B Lignocaine, Mexilitine, Phenytoin 1C Flecainide 2 Beta Blockers Metoprolol, Atenolol, Propranolol 3 K+ efflux blockers Amiodarone, Bretylium, Sotalol 4 Calcium Channel Blockers Verapamil, Diltiazem Unclassified Various mechanisms MgS04, Adenosine, Isoprenaline, Digoxin
10 Class1: fast Na+ channel blockers Red shading = Commonly used drugs Vaughan Williams subdivides Type 1 into 1a: quinidine, procainamide, disopyramide 1b: lignocaine, mexilitine, phenytoin^^ 1c: flecainide ^^ phenytoin s main use is for seizure prophylaxis
11 Class1a Not commonly used
12 Class1b Lignocaine DRUG CLASS MECHANISM USES/DOSE SIDE EFFECTS /INTERACTS Class 1b Fast Na+ channel blocker Reduces automaticity Negative inotrope No effect AV node VT and VF Rx: IV 100mg slow push, then IV 2-4 mg/min. S/E s: Proarrhythmic, dizziness, paraesthesiae, seizures, hypotension, resp depr, coma Metab: hepatic Inter: Flecainide: negative inotrope. Electrolyte disturbances: correct before use C/Ix AV Block, CCF
13 Class1c DRUG CLASS MECHANISM USES/DOSE INTERACTS Flecainide Class 1c Incr Refractory period esp His-Purk Negative inotrope SVT, AFlutter, Reverts PAF,( equiv to Amiodarone.) 2 nd line for refractory VT/VF Rx: IV 100mg slow push in 5% Dextrose, oral mg at onset AF symptoms, Maint oral 50mg bd S/E s: Neg inotrope, Proarrhythmic Electrolyte disturbances: correct before use, may cause heart block C/Ix AV Block, CCF, SSS Inter: C/Ix with Disopyramide
14 Beta adrenergic receptor pharmacology a quick review Beta 1 stimulation: pos inotrope/chronotrope, pos automaticity, pos AV node conduction velocity, increases renin release>>increases aldosterone/angiotensin levels. Beta 1 inhibition: neg inotrope/chronotrope, neg automaticity, inhibits conduction velocity AV node, inhibits renal renin release>>reduces aldosterone/angiotensin levels Beta 2 stimulation: smooth muscle relaxation, vasodilatation in skeletal muscle and tremor, glycogenolysis in liver/ skeletal muscle, uterine relaxation, reduced peripheral vascular resistance Beta 2 inhibition: bronchospasm, peripheral arteriolar vasoconstriction so use caution in ASTHMA, PVD!, inhibits glycogen breakdown in liver/skeletal muscle
15 Why beta blockers rock Long term beta blocker use after MI reduces mortality by 25%, due to the reduction in cardiac workload and 02 demand, however 25% develop significant side effects including bradycardia, AV Block, asthma, hypotension
16 Class 2: Beta Blockers Beta Blockers act at different sites in the myocardium Variable Mechanisms of Beta Blocker Actions Representative Beta Blocker examples Variable sites of action Slows AV conduction velocity Propranolol (NON SELECTIVE: BETA 1 AND BETA 2) Inhibits AV node conduction Metoprolol and Atenolol (BETA 1 SELECTIVE) Prolongs PR (class 2) and QT interval (class 3) Sotalol Mixed Beta and Alpha-1 Blocker effect Labetalol
17 Beta blockers.. Effect Mechanism Examples Cardioselective Beta 1 receptor blockers Metoprolol, Atenolol Membrane stabilisers Prolong QRS Propranolol Alpha and beta blockade Block both adrenergic effects Labetalol Intrinsic Sympathomimetic Activity Insignificant Beta Agonist effect also??helpful in CCF Pindolol, Alprenolol, Oxprenolol
18 Comparing beta blockers DRUG RECEPTORS BLOCKED ISA (antagonist and partial agonist) METABOLISM Atenolol Beta 1 0 renal 1 Metoprolol Beta 1 0 liver 1-2 Sotalol Beta 1 beta 2 0 liver 2 Pindolol, Oxprenolol Beta 1 beta 2 +++?Better in PVD; does not help survival after MI liver 2-3 Propranolol Beta 1 beta 2 0 liver 2-3 DOSES/DAY
19 Beta Blockers and arrhythmias DRUG Beta receptor blocked MECHANISM DOSE SIDE EFFECTS /INTERACTS Arrhythmias used for Propranolol Beta 1 and 2 Blocks adrenaline binding at the receptor Reduced myoc contractility, slowed SA AV automaticity and cond veloc 10-40mg o tds S/Es: bradycardia, bronchospasm, cool peripheries, nightmares, depression, fatigue Sinus tachy including hyperthyroidism, rate control AF, increase AV block in AFlutter Metoprolol Beta 1 IV 1mg increments; usually mg oral q12-24h Atenolol Beta mg oral daily Sotalol Beta 1 and 2, and Prolongs RP, and Slows Refractory Period: Atria, AV.Ventricles, mg oral bd also exercise induced VT also exercise induced VT Proarrhythmic including long QT and ventric torsades. Brady/ Most Atrial, ventricular tachyarrhythmias; not effective in
20 Class 3: K+ channel blockers Bretylium Amiodarone Sotalol
21 Class 2 and 3: Sotalol Sotalol: Mimics Class 3 antiarrhythmics (The Class 3 agents are Amiodarone, Bretylium and Sotalol: they prolong myocardial refractoriness and repolarisation without affecting conduction) as well as having a noncardioselective beta adrenergic blocking effect
22 Amiodarone DRUG CLASS MECHANISM DOSE SIDE EFFECTS /INTERACTS Arrhythmias used for Amiodarone Class 3 K+ channel blocker Also some Na+ channel blocker (Class 1), Also some beta blocker and CCB effect. Structurally similar to Thyroxine. Long acting half life days Not negative inotrope so is useful in CCF. Decreases SA and AV node automaticity. Prolongs Refractory period of all myocardium. Weak beta blocker effect on rate. IV 300mg then infusion 15mg/kg over 24 hrs, in 5%Dextrose Oral mg daily C/Ix Cardiogenic shock C/Ix AV Block Many. Proarrhythmic. Photosensitisatio n, skin pigment, corneal deposits, thyroid,pulm fibrosis, Periph Neuropathy, long QT and torsades. Hepatotoxic, nausea. Interacts: potentiates Digoxin levels and Warfarin Equivalent to Flecainide in reverting PAF; VT reversion; VF after Defib; PVCs; SVT incl WPW; Aflutter; prevent PAF C/Ix AV Block C/Ix Cardiogenic shock
23 Calcium Channel Blockers Centrally acting: reduce heart rate, cardiac contractility, and conduction. Minimal peripheral effects. Phenylalkylamine class: Verapamil; Benzothiazepine class: Diltiazem*, Peripherally acting: relax vascular smooth muscle. Minimal effect on myocardium. Dihydropyridine class: Amlodipine, Nifedipine; also Benzothiazepine class: Diltiazem* Diltiazem overlaps central and peripheral effect
24 Calcium Channel Blockers DRUG Examples CLASS MECHANISM DOSE SIDE EFFECTS /INTERACTS Arrhythmias used for Verapamil Phenylalkylamine Block L-type Calcium channels Reduces HR Conduction velocity. Negative Inotrope mg tds: Hypotension, C/Ix in CCF, peripheral oedema, headache, flushing Prevent and treat SVT, rate control in AF, STc Nifedipine Amlodipine Dihydropridines Block L-type Calcium channels Relaxes peripheral vascular smooth muscle Nifed:10-30mg daily for HT Amlod: 5-10mg; used for HT Reflex tachycardia, peripheral oedema, headache, flushing Not for arrhythmias Diltiazem Benzothiazepine Block L-type Calcium channels Mixed effects 60mg tds antianginal Similar to above Anti-anginal; some effects STc SVT
25 Adenosine DRUG CLASS MECHANISM DOSE SIDE EFFECTS /INTERACTS Arrhythmias used for Adenosine nucleoside Depresses conduction AV node Metabolised by cellular uptake into erythrocytes. 3-6mg rapid IV bolus and flush. 12mg if not successful Rapid onset and offset ~ half life is 10 seconds. Bronchospasm, headache, anxiety Relative C/Ix with Verapamil or Digoxin as may rarely cause VF Reverts SVT including WPW. Diagnostic in Aflutter Transient AV blockade in AF. No effect on Ventricular arrhythmias Dipyridamole and carbemazepine enhance adenosine heart bl;ock effect Use Midazolam 1-2mg IV as premed to reduce anxiety C/Ix Bradycardia or CHB
26 Which conduction disorder is this?
27 Atropine DRUG CLASS MECHANISM DOSE SIDE EFFECTS /INTERACTS Arrhythmias used for Atropine Anticholinergic: Competitive blockade muscarinic ACh receptors in CNS and parasympathetic NS Bradycardia with compromised haemodynamics: -IV 1 mg (adult); repeat x 2 as needed (total 3mg) Asystole: 6mg IV once only S/E s: tachycardia, dry mouth, mydriasis, photophobia, urinary retention, delirium, fever Bradyarrhythmia s with haemodynamic compromise Adrenaline is the initial drug of choice for asystole Also for organophosphat e poisoning with bradycardia.
28 Digoxin DRUG CLASS MECHANISM DOSE SIDE EFFECTS /INTERACTS Arrhythmias used for Digoxin Cardiac glycoside Increases force of contraction and inhibits AV node conduction IV: 0.5mg IV over 5 mins 4-6 hourly to total 1.5mg. Oral mg daily. Yellow vision, bradycardia, atrial tachy with bundle block, vomiting, proarrhythmic AF rate control SVT reversion or prevention of PAF CCF at lower doses Therapeutic level nmol/l Renal excretion 70%
29 Isoprenaline DRUG CLASS MECHANISM DOSE SIDE EFFECTS /INTERACTS Arrhythmias used for Isoprenaline Beta AGONIST (beta 1 and beta 2) Positive inotrope, chronotrope. Increases automaticity and AV conduction. Increases systolic BP; decreases diastolic BP due to peripheral vasodilatation. Coronary vasodilator. IV: 20mcg IV over 2 mins; infusion mcg/kg/min titrated to heart rate. Headache, tachycardia, BP up or down, angina. It increases cardiac workload and oxygen demand like all sympathomimetic agonists. Bradycardia, complete heart block, adjunct in septic or cardiogenic shock. Use vasopressors as well and fluid. Use with CHB while arranging urgent pacing.
30 Questions?
ACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
More informationANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
More informationACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
ACLS Cardiac Arrest Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767 Copyright 2010 American Heart Association ACLS Cardiac Arrest Circular Algorithm Neumar, R. W. et al. Circulation 2010;122:S729-S767
More informationMEDICATIONS USED IN ADULT CODE BLUE EMERGENCIES. Source: ACLS Provider Manual. American Heart Association. 2001, 2002. Updated 2003.
MEDICATIONS USED IN ADULT CODE BLUE EMERGENCIES Source: ACLS Provider Manual. American Heart Association. 2001, 2002. Updated 2003. 1 ET Administration Atropine o First drug for symptomatic sinus bradycardia
More informationAtrial & Junctional Dysrhythmias
Atrial & Junctional Dysrhythmias Atrial & Junctional Dysrhythmias Atrial Premature Atrial Complex Wandering Atrial Pacemaker Atrial Tachycardia (ectopic) Multifocal Atrial Tachycardia Atrial Flutter Atrial
More informationGUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)
AUSTRALIAN RESUSCITATION COUNCIL GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support) The term cardiac arrhythmia
More informationHypertension and Heart Failure Medications. Dr William Dooley
Hypertension and Heart Failure Medications Dr William Dooley Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications Heart Failure Aims; Short term:
More informationAntiarrhythmic drug pharmacology
Antiarrhythmic drug pharmacology Samuel C. Dudley, Jr., M.D., Ph.D. 6/7/2003 1 Setting the membrane potential Nernst E eq [ S] = 61log i [ S] o Current I Na Equil. Pot. +60 mv Effect on E m Depolarize
More information8 Peri-arrest arrhythmias
8 Peri-arrest arrhythmias Introduction Cardiac arrhythmias are relatively common in the peri-arrest period. They are common in the setting of acute myocardial infarction and may precipitate ventricular
More informationStimulates HR, BP, CO, and vasoconstriction. Stimulates renal, venous, mesenteric arterial. basic chart below) (alpha receptors) vasoconstriction
Bolus Alternate Range Drip ACLS Drugs and Drips Amiodarone / Cordarone Lidocaine Procainamide / Pronestyl Dopamine / Intropin CARDIAC ARREST PULSELESS VT/VF Arrest Kit: (300mg bolus) Amiodarone 6 Vial
More informationRecurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
More informationAtrial Fibrillation Management Across the Spectrum of Illness
Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,
More informationAdrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers
Adrenergic, Adrenergic Blockers, Cholinergic and Cholinergic Blockers Objective 1: Explain the difference between the sympathetic and parasympathetic nervous systems Autonomic Nervous System Sympathetic
More informationCurrent Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
More informationCrash Cart Drugs Drugs used in CPR. Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University
Crash Cart Drugs Drugs used in CPR Dr. Layla Borham Professor of Clinical Pharmacology Umm Al Qura University Introduction A list of the drugs kept in the crash carts. This list has been approved by the
More informationInotropes/Vasoactive Agents Hina N. Patel, Pharm.D., BCPS Cathy Lawson, Pharm.D., BCPS
Inotropes/Vasoactive Agents Hina N. Patel, Pharm.D., BCPS Cathy Lawson, Pharm.D., BCPS 1. Definition -an agent that affects the contractility of the heart -may be positive (increases contractility) or
More informationPRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia
PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right
More informationAdult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES
Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal
More informationGlucagon stimulates adenyl cyclase. Amrinone and milrinone inhibit phosphodiesteras e
Beta-Adrenergic Blocker Poisoning John Gualtieri, PharmD Clinical Assistant Professor Dept. of Experimental and Clinical Pharmacology College of Pharmacy, Univ of Minnesota I. Objectives 1.) Described
More informationEfficacy and Safety of Pharmacological Options for Rate Control in Atrial Fibrillation
AACN Advanced Critical Care Volume 23, Number 2, pp.120 125 2012, AACN ECG Challenges Earnest Alexander, PharmD, and Gregory M. Susla, PharmD Department Editors Efficacy and Safety of Pharmacological Options
More information!!! BOLUS DOSE IV. Use 5-10 mcg IV boluses STD ADRENALINE INFUSION. Use IM adrenaline in advance of IV dosing!
ADRENALINE IVI BOLUS IV Open a vial of 1:1000 ADRENALINE 1 mg /ml Add 1 ml to 9 ml N/Saline = 1mg adrenaline in 10 ml (or 100 mcg/ml) Add 1 ml 1:10,000 to 9 ml N/Saline = 100 mcg adrenaline in 10 ml (or
More informationCardiac Arrest VF/Pulseless VT Learning Station Checklist
Cardiac Arrest VF/Pulseless VT Learning Station Checklist VF/VT 00 American Heart Association Adult Cardiac Arrest Shout for Help/Activate Emergency Response Epinephrine every - min Amiodarone Start CPR
More informationAtrial Fibrillation Peter Santucci, MD Revised May, 2008
Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is
More informationElectrolyte Physiology. Something in the way she moves
Electrolyte Physiology Something in the way she moves me Electrolyte Movement CONCENTRATION GRADIENT ELECTRICAL GRADIENT DRIVING FORCE NERNST NUMBER (E-ion) CONDUCTANCE (G-ion) PERMEABILITY CHANNELS: small
More informationGuideline for the management of arrhythmias
Guideline for the management of arrhythmias The following guideline is approved only for use at University College London Hospitals NHS Foundation Trust. It is provided as supporting information for the
More informationArrest. What s a Nurse to do?
Benzo s, Blockers, Coma & Cardiac Arrest What s a Nurse to do? Objectives Review of ACLS Algorithms for Cardiac Arrest Management Discuss the toxicology of Beta Blocker Poisoning Describe the clinical
More informationATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
More informationPresenter Disclosure Information
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
More informationtable of contents drug reference
table of contents drug reference ADULT DRUG REFERENCE...155 161 PEDIATRIC DRUG REFERENCE...162 164 PEDIATRIC WEIGHT-BASED DOSING CHARTS...165 180 Adenosine...165 Amiodarone...166 Atropine...167 Defibrillation...168
More informationPharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System
Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System Question No. 1 of 10 Instructions: (1) Read the problem and answer choices carefully, (2) Work the problems on paper as 1. What
More informationCardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias
Cardiovascular System & Its Diseases Lecture #4 Heart Failure & Cardiac Arrhythmias Dr. Derek Bowie, Department of Pharmacology & Therapeutics, Room 1317, McIntyre Bldg, McGill University derek.bowie@mcgill.ca
More informationHere is a drug list that you need to know before taking the NREMT-P exam!! Taken from the book EMS NOTES.com
Here is a drug list that you need to know before taking the NREMT-P exam!! Taken from the book EMS NOTES.com Special thanks to the number #1 internet training site id44.com and also to (NOTE) Please remember
More informationPREPARATIONS: Adrenaline 1mg in 1ml (1:1000) Adrenaline 100micrograms in 1ml (1:10,000)
ADRENALINE Acute hypotension Via a CENTRAL venous line Initially 100-300 nanograms/kg/minute 0.1-0.3 microgram/kg/minute adjusted according to response up to a maximum of 1.5 micrograms/kg/minute. Increase
More informationPresent : PGY 王 淳 峻 Supervisor: F1 王 德 皓 991109
Present : PGY 王 淳 峻 Supervisor: F1 王 德 皓 991109 Interventions to prevent cardiac arrest + Airway management + Ventilation support + Treatment of bradyarrhythmias & Tachyarrhythmias Treat cardiac arrest
More informationACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY
Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF
More informationAdding IV Amiodarone to the EMS Algorithm for Cardiac Arrest Due to VF/Pulseless VT
Adding IV Amiodarone to the EMS Algorithm for Cardiac Arrest Due to VF/Pulseless VT Introduction Before the year 2000, the traditional antiarrhythmic agents (lidocaine, bretylium, magnesium sulfate, procainamide,
More informationChapter 13. Sympathetic Nervous System. Basic Functions of the Nervous System. Divisions of the Peripheral Nervous System
Chapter 13 Drugs Affecting the Autonomic Basic Functions of the Recognizing changes in Internal environment External environment Processing and integrating changes Reacting to changes Upper Saddle River,
More informationThe Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
More informationKey Points. Autonomic Nervous System Drugs. Autonomic effects Sympathetic. Drugs can modify ANS activity by: Autonomic Nervous System
Key Points Autonomic Nervous System Drugs Autonomic drugs work at the synapses, Drugs either suppress or magnify the sympathetic or parasympathetic effect, Drugs don t work on a single target organ so
More informationAdrenergic agonists. R. A. Nimmi Dilsha Department of pharmacy Faculty of Health Sciences The Open University of Sri Lanka
Adrenergic agonists R. A. Nimmi Dilsha Department of pharmacy Faculty of Health Sciences The Open University of Sri Lanka Outline Recall Introduction to adrenergic agonists Classification of adrenergic
More informationANZCOR Guideline 12.4 Medications and Fluids in Paediatric Advanced Life Support
ANZCOR Guideline 12. Medications and Fluids in Paediatric Advanced Life Support Who does this guideline apply to? This guideline applies to infants and children. Summary Who is the audience for this guideline?
More informationPharmacology Drug Chart
Pharmacology Drug Chart Cholinergic Agonists Acetylcholine Muscarinic HR, CO and BP Salivary Secretions Secretions and Motility in the GIT Bronchiolar Secretions Miosis (Constriction of the Pupil) Pharmacology
More informationPHENYLEPHRINE HYDROCHLORIDE INJECTION USP
PRESCRIBING INFORMATION PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 10 mg/ml Sandoz Canada Inc. Date of Preparation: September 1992 145 Jules-Léger Date of Revision : January 13, 2011 Boucherville, QC, Canada
More informationMedical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
More informationAlabama Medications. Christopher J. Colvin January 2010
Alabama Medications Christopher J. Colvin p January 2010 Activated Charcoal Used to absorb toxins ingested before they can be absorbed in the GI system. Contraindicated in AMS patients who cannot control
More informationHTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)
HTEC 91 Medical Office Diagnostic Tests Week 4 Topic for Today: Atrial Rhythms PACs: Premature Atrial Contractions PAT: Paroxysmal Atrial Tachycardia AF: Atrial Fibrillation Atrial Flutter Premature Atrial
More informationSeptic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident
Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor
More informationATRIAL FIBRILLATION (AF) DRUG INFORMATION
Australia www.atrialfibrillation-au.org Providing information, support and access to established, new or innovative treatments for Atrial Fibrillation ATRIAL FIBRILLATION (AF) DRUG INFORMATION Copyright
More informationPHARMACOLOGY OF VNS VARIANT 1 1) Anti-ChEs: contraindications and precautions. 2) Examples of Cholinesterase reactivators. 3) Cholinoblockers-natural
VARIANT 1 Anti-ChEs: contraindications and precautions. Examples of Cholinesterase reactivators. Cholinoblockers-natural alkaloids (examples). 4) GIT-effects of Atropine. 5) Pharmacologic characteristic
More informationATRIAL FIBRILLATION IN CRITICAL CARE AMIODARONE OR DIGOXIN?
UNIT FARMASI KLINIKAL (UFK), HUSM. ATRIAL FIBRILLATION IN CRITICAL CARE AMIODARONE OR DIGOXIN? PRECEPTOR: PN KHAIRUL BARIAH KHOR KAH LOONG HUSM PRP 2011/12 Presentation Outline Objectives Introduction
More informationADRENERGIC RECEPTOR AGONIST,CLASSIFICATION AND MECHANISM OF ACTION.
ADRENERGIC RECEPTOR AGONIST,CLASSIFICATION AND MECHANISM OF ACTION. LEARNING OBJECTIVES At the end of lecture students should be able to know, Adrenergic receptor agonist, Classification and mechanism
More informationRUSSELLS HALL HOSPITAL EMERGENCY DEPARTMENT
RUSSELLS HALL HOSPITAL EMERGENCY DEPARTMENT CLINICAL GUIDELINE ATRIAL FIBRILLATION March 2011 For quick links to AF algorithms: UNSTABLE PATIENT STABLE PATIENT - 1 - Introduction Atrial fibrillation is
More informationATRIAL FIBRILLATION AND ANAESTHESIA
ATRIAL FIBRILLATION AND ANAESTHESIA Dr AD Theron, SHO in Anaesthesia, Royal Devon and Exeter Hospital, Exeter, UK. E-mail: drabrietheron@yahoo.co.uk Atrial fibrillation (AF) is one of the commonest arrhythmias.
More informationHow To Treat An Arrhythmia
Drug Treatment for Heart Rhythm Disorders (Arrhythmia) Promoting better understanding, diagnosis, treatment and quality of life for those affected by heart rhythm disorders (cardiac arrhythmias) www.heartrhythmcharity.org.uk
More informationUpdate on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new?
Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new? DVM, DACVA Objective: Update on the new Small animal guidelines for CPR and a discussion of the 2012 Reassessment Campaign on
More informationWide-Complex Tachycardias in the ED: Myths and Pitfalls
Wide-Complex Tachycardias in the ED: Myths and Pitfalls, FACEP, FAAEM Professor and Vice Chair Director, Emergency Cardiology Fellowship Department of Emergency Medicine University of Maryland School of
More informationDIPHENHYDRAMINE (Benadryl)
DIPHENHYDRAMINE (Benadryl) Classification: Antihistamine (H1 blocker) Antihistamine; appear to compete with histamine for cell receptor sites on effector cells. Therapeutic Relieves effects of histamine
More informationEquine Cardiovascular Disease
Equine Cardiovascular Disease 3 rd most common cause of poor performance in athletic horses (after musculoskeletal and respiratory) Cardiac abnormalities are rare Clinical Signs: Poor performance/exercise
More informationAtrial fibrillation (AF) care pathways. for the primary care physicians
Atrial fibrillation (AF) care pathways for the primary care physicians by University of Minnesota Physicians Heart, October, 2011 Evaluation by the primary care physician: 1. Comprehensive history and
More informationNormal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent.
Normal Sinus Rhythm (NSR) Rate: 60-100 per minute Rhythm: R- R = P waves: Upright, similar P-R: 0.12-0.20 second & consistent P:qRs: 1P:1qRs Sinus Tachycardia Exercise Hypovolemia Medications Fever Hypoxia
More informationAtrial fibrillation (AF) drug information
AF A Atrial fibrillation (AF) drug information Providing information, support and access to established, new or innovative treatments for Atrial Fibrillation www.afa.org.uk Registered Charity No. 1122442
More informationHIGH DOSE INSULIN IN BETA BLOCKER AND CALCIUM CHANNEL BLOCKER OVERDOSE
HIGH DOSE INSULIN IN BETA BLOCKER AND CALCIUM CHANNEL BLOCKER OVERDOSE TOM SCULLARD RN MSN CCRN CLINICAL CARE SUPERVISOR MEDICAL INTENSIVE CARE UNIT HENNEPIN COUNTY MEDICAL CENTER MINNEAPOLIS MINNESOTA
More informationMetoprolol succinate (Ph. Eur.) 23.75 mg, 47.5 mg, 95 mg and 190 mg controlled-release tablets
AFT-Metoprolol CR Metoprolol succinate (Ph. Eur.) 23.75 mg, 47.5 mg, 95 mg and 190 mg controlled-release tablets Presentation AFT-METOPROLOL CR tablets 23.75 mg are white, oval, biconvex, film-coated tablets
More informationACLS PRE-TEST ANNOTATED ANSWER KEY
ACLS PRE-TEST ANNOTATED ANSWER KEY June, 2011 Question 1: Question 2: There is no pulse with this rhythm. Question 3: Question 4: Question 5: Question 6: Question 7: Question 8: Question 9: Question 10:
More informationTOP 5. The term cardiac arrhythmia encompasses all cardiac. Arrhythmias in Dogs & Cats. Sinus Arrhythmia. TOP 5 Arrhythmias Seen in Dogs & Cats
Top 5 ardiology Peer reviewed TOP 5 rrhythmias in Dogs & ats shley Jones, DVM mara Estrada, DVM, DVIM (ardiology) University of Florida The term cardiac arrhythmia encompasses all cardiac rhythms other
More informationAnti Arrhythmic Agents
Introduction to Antiarrhythmic Agents Munther K. Homoud, MD Tufts-New England Medical Center Spring 2008 Anti Arrhythmic Agents Introduction to anti arrhythmic agents Mechanisms of arrhythmogenesis Management
More informationHEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise
WEEK 3 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease HEART FAILURE Heart failure can be defined as the failing (insufficiency) of the heart as a mechanical pump due to either acute
More informationEPINEPHRINE Injection, USP 1:1000 (1 mg/ml) Ampul Protect from light until ready to use.
EPINEPHRINE Injection, USP 1:1000 (1 mg/ml) Ampul Protect from light until ready to use. R x only DESCRIPTION Epinephrine Injection, USP 1:1000 is a sterile, nonpyrogenic solution. Each ml contains epinephrine
More informationNovartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf
More informationAmerican Heart Association ACLS Pre-Course Self Assessment Dec., 2006. ECG Analysis. Name the following rhythms from the list below:
American Heart Association ACLS Pre-Course Self Assessment Dec., 2006 ECG Analysis This pre-test is exactly the same as the pretest on the ACLS Provider manual CD. This paper version can be completed in
More informationSign up to receive ATOTW weekly - email worldanaesthesia@mac.com
ADRENALINE (EPINEPHRINE) ANAESTHESIA TUTORIAL OF THE WEEK 226 6 TH JUNE 2011 Prof. John Kinnear Southend University Hospital NHS Foundation Trust, UK Correspondence to John.Kinnear@southend.nhs.uk QUESTIONS
More informationSign up to receive ATOTW weekly - email wfsahq@anaesthesiologists.org
ATRIAL FIBRILLATION (AF). PERI-OPERATIVE MANAGEMENT FOR NON-CARDIAC SURGERY ANAESTHESIA TUTORIAL OF THE WEEK 307 28 th APRIL 2014 Dr J Sokhi Southend University Hospital, UK Professor J Kinnear Southend
More informationAdrenergic receptors lec 9, part 2. 16/10/2014 Dr. Laila M. Matalqah Rama Kamal Ali Treany
Adrenergic receptors lec 9, part 2 16/10/2014 Dr. Laila M. Matalqah Rama Kamal Ali Treany Pharmacology of ANS Adrenergic Agonists Adrenergic receptors:- - It is a receptor which is located in the peripheral
More informationPRO-CPR. 2015 Guidelines: PALS Algorithm Overview. (Non-AHA supplementary precourse material)
PRO-CPR 2015 Guidelines: PALS Algorithm Overview (Non-AHA supplementary precourse material) Please reference Circulation (from our website), the ECC Handbook, or the 2015 ACLS Course Manual for correct
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More informationAtrial Fibrillation (AF) Drug Information
AF A Atrial Fibrillation (AF) Drug Information Providing information, support and access to established, new or innovative treatments for Atrial Fibrillation www.atrialfibrillation-au.org Glossary Anti-arrhythmic
More informationCALCIUM CHANNEL BLOCKING DRUGS
The calcium channel blocking drugs (CCBs) are a heterogeneous group of compounds that are classified according to chemical structure: diphenylalkylamines (verapamil), benzothiazepines (diltiazem), dihydropyridines
More informationDocetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer
Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer Background: A non-anthracycline based regimen for high-risk, HER 2 positive breast cancer in the adjuvant setting (BCIRG 006). Patient
More informationADVANCED LIFE SUPPORT LEARNING PACKAGE
SOUTH WEST HEALTHCARE WARRNAMBOOL ADVANCED LIFE SUPPORT LEARNING PACKAGE Prepared by: J. Brown, ICU Last revised February, 2010. C. Joseph, Nursing Education. CONTENTS: Page: Objectives 3-5 Basic Life
More informationSPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE
SPECIALTY : CARDIOLOGY CLINICAL PROBLEM: HEART FAILURE Summary Heart failure has a worse prognosis than many cancers with an annual mortality of 40% in the first year following diagnosis and 10% thereafter.
More informationCoronary artery disease
Oxford Medicine Online You are looking at 1-8 of 8 items for: UA oxford_medical_handbooks CAR0040 Coronary artery disease Punit Ramrakha and Jonathan Hill (eds) Print Publication Year: 2012 Published Online:
More informationMilwaukee School of Engineering Gerrits@msoe.edu. Case Study: Factors that Affect Blood Pressure Instructor Version
Case Study: Factors that Affect Blood Pressure Instructor Version Goal This activity (case study and its associated questions) is designed to be a student-centered learning activity relating to the factors
More informationNgaire has Palpitations
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
More informationLESSON ASSIGNMENT. 7-4. Given a group of statements, select the best definition of the term adrenergic (sympathomimetic) drug.
LESSON ASSIGNMENT LESSON 7 Adrenergic Agents. TEXT ASSIGNMENT Paragraphs 7-1 through 7-6. LESSON OBJECTIVES 7-1. Given a group of statements, select the mechanism(s) of action of drugs which stimulate
More informationPediatric Pharmacotherapy A Monthly Newsletter for Health Care Professionals Children s Medical Center at the University of Virginia
Pediatric Pharmacotherapy A Monthly Newsletter for Health Care Professionals Children s Medical Center at the University of Virginia Volume 2 Number 12 December 1996 Medications for Neonatal and Pediatric
More informationAdrenergic agonists:-
Adrenergic agonists:- A.) Catecholamines They are called catecholamines because they contain a catechol group, they are water-soluble and are 50% bound to plasma proteins, so they circulate in the bloodstream.
More informationPharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant
REVIEW Pharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant Judy W.M. Cheng 1 and Iwona Rybak 2 1 Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences and
More informationDrugs affecting the autonomic nervous system. Objectives. Autonomic Nervous System (ANS) 12/23/2014
Drugs affecting the autonomic nervous system N231 Nursing Pharmacology Objectives Analyze the implementation of the nursing process in the promotion and maintenance of system stability for individuals
More informationEssential facts for med-surg nurses
Emergency cardiac drugs: Essential facts for med-surg nurses Emergencies on a med-surg unit can be daunting. By Ira Gene Reynolds, MSNEd, RN, PCCN-CMC IN THE HOSPITAL SETTING, emergencies typically occur
More informationADRENERGIC AND ANTI-ADRENERGIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
ADRENERGIC AND ANTI-ADRENERGIC DRUGS Mr. D.Raju, M.pharm, Lecturer SYMPATHETIC NERVOUS SYSTEM Fight or flight response results in: 1. Increased BP 2. Increased blood flow to brain, heart and skeletal muscles
More informationEpisode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier
Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier Most common dysrhythmia seen in ED, and incidence increasing with ageing population Presentation Common presentations: younger patients often
More informationManagement of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
More informationWhat is the Future of Epinephrine in Cardiac Arrest? Pros and Cons
What is the Future of Epinephrine in Cardiac Arrest? Pros and Cons Melissa L. Thompson Bastin, PharmD., BCPS Komal A. Pandya, PharmD., BCPS 0 Presenter Disclosure Information Melissa L. Thompson Bastin,
More informationthe basics Perfect Heart Institue, Piyavate Hospital
ECG INTERPRETATION: the basics Damrong Sukitpunyaroj MD Damrong Sukitpunyaroj, MD Perfect Heart Institue, Piyavate Hospital Overview Conduction Pathways Systematic Interpretation Common abnormalities in
More informationPhilip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth
Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth I. II. Background A. AWS can occur in anyone who consumes alcohol B. Risk correlates
More information20150113 (NL/H/0795-809-810/001-002) FLECAINIDE ACETATE 100 MG; 50 MG TABLET 800-1126.00 800-1127.00. Package leaflet: Information for the user
Sandoz Business use only Page 1 of 6 Package leaflet: Information for the user [Nationally completed name] 50 and 100 mg tablets Flecainide acetate Read all of this leaflet carefully before you start taking
More informationBradycardia CHAPTER 12 CODE SCENARIO
Senecal-12.qxd 14/04/2005 09:44 AM Page 69 CHAPTER 12 Bradycardia CODE SCENARIO A code is called for a 78-year-old man who was admitted to the hospital for syncope of unknown etiology. He was resting comfortably
More informationHYPERTENSION MANAGEMENT
DISCLAIMER: These guidelines were prepared jointly by the Surgical Critical Care and Medical Critical Care Services at Orlando Regional Medical Center. They are intended to serve as a general statement
More informationQuiz 4 Arrhythmias summary statistics and question answers
1 Quiz 4 Arrhythmias summary statistics and question answers The correct answers to questions are indicated by *. All students were awarded 2 points for question #2 due to no appropriate responses for
More informationNEW ONSET ATRIAL FIBRILLATION IN THE SURGICAL PATIENT
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
More information